Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
IJSREM44128
Volume:
9 |
4 |
Apr 2025
Pages:
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
Alzheimerâs disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive decline, and its underlying mechanisms involve intricate interactions between genetic and proteomic factors. Genomics and proteomics play a crucial role in understanding Alzheimerâs disease by identifying genetic risk factors. Recent advancements in genomics and proteomics have enabled researchers to develop deeper into the molecular pathways implicated in AD. Genomic studies have uncovered various genetic variants associated with increased risk for AD, particularly in genes such as APP, APOE, TREM2, CLU, CD33, PSEN1 & 2 proteins like Aβ, Tau. Our current understanding of AD pathologies involves various hypotheses, such as the cholinergic, amyloid, tau protein, inflammations, etc.
KEYWORDS
Publication Date
4/9/2025
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
0
Total views since publication
PDF Downloads
0
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...